Clinical resolution of type 2 diabetes with reduction in body mass index using meal replacement based weight loss

Vascular Disease Prevention

Volumn 5, Issue 1, 2008, Pages 17-23

  Nori Janosz, Katherine E ^a   Koenig Berris, Karen A ^a   Leff, Carrie ^a   Miller, Wendy M ^a   Yanez, Jose ^a   Myers, Samantha ^a   Vial, Claire ^a   VanderLinden, Merry ^a   Franklin, Barry A ^a   McCullough, Peter A ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

BMI (body mass index); Diabetes; Glycosylated hemoglobin; Meal replacement; Obesity; Portion control; Waist circumference; Weight loss

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; GLITAZONE DERIVATIVE; GLYCOSYLATED HEMOGLOBIN; INSULIN; METFORMIN;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIET THERAPY; DISEASE ASSOCIATION; FEMALE; HOSPITAL ADMISSION; HUMAN; LOW CALORY DIET; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; SEX RATIO; SUBURBAN AREA; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

EID: 40549142735     PISSN: 15672700     EISSN: None     Source Type: Journal    
DOI: 10.2174/156727008783503134     Document Type: Article

References (47)

1. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002; 288: 1723-7.
2. Centers for Disease Control (CDC)-Diabetes. http://www.cdc.gov/diabetes. accessed July 10, 2007.
3. International Diabetes Federation (IDF) http://www.idf.org accessed July 10, 2007.
4. Lloyd-Jones DM, Liu K, Colangelo LA, Yan LL, Klein L. Consistently stable body mass index and changes in risk factors associated with the metabolic syndrome. Circulation 2004, Abstract 3567.
5. CDC National Diabetes Fact Sheet. www.CDC.gov/diabetes accessed September 6, 2005.
6. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-53.
7. Maggio CA, Pi-Sunyer FX. Obesity and type 2 diabetes Endocrinol Metab Clin N Am 2003; 32: 805-22.
8. Must A, Spadano J, Coakly EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA 1999; 282: 1523-9.
9. Grundy SM, Howard B, Smith S Jr, Eckel R, Redberg R, Bonow RO. Prevention Conference VI: Diabetes and cardiovascular disease: executive summary: conference proceedings for healthcare professionals from a special writing group of the American Heart Association. Circulation 2002; 105: 2231-9.
10. Cho E, Manson JE, Stampfer MJ, et al. A prospective study of obesity and risk of coronary heart disease among diabetic women. Diabetes Care 2002; 25: 1142-8.
11. DECODE Study Group, the European Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 2001; 161: 397-405.
12. Anderson JW, Kendall CW, Jenkins DJ. Importance of weight management in type 2 diabetes: review with meta-analysis of clinical studies. J Am Coll Nutr 2003; 22: 331-9.
13. Pi-Sunyer FX. Comorbidities of overweight and obesity: current evidence and research issues. Med Sci Sports Exerc 1999; 31: S602-S608.
14. Pi-Sunyer FX. Medical hazards of obesity. Ann Intern Med 1993; 119: 655-60.
15. Wilson PW, D'Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 2002; 162: 1867-72.
16. Krauss RM, Winston M, Fletcher RN, Grundy SM. Obesity: impact of cardiovascular disease. Circulation 1998; 98: 1472-6.
17. Franz MJ, Bantle JP, Beebe CA, et al. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care 2003; 26: S51-61.
18. Dixon JB, O'Brien PE. Health outcomes of severely obese type 2 diabetic subjects 1 year after laproscopic adjustable gastric banding. Diabetes Care 2002; 25: 358-63.
19. Yanovski SZ, Yanovski JA. Obesity. N Engl J Med 2002; 346: 591-602.
20. McTigue KM, Harris R, Hemphill B, et al. Screening and interventions for obesity in adults: summary of the evidence for the US Prevention Services Task Force. Ann Intern Med 2003; 84: 1470-4.
21. Anderson JW, Luan J, Hoie LH. Structured weight-loss programs: meta-analysis of weight loss at 24 weeks and assessment of effects of intervention intensity. Adv Ther 2004; 21: 61-75.
22. Klein S, Burke LE, Bray GA, et al. American Heart Association Council on Nutrition, Physical Activity, and Metabolism. Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation 2004; 110: 2952-67.
23. CDC website for treatment of obesity. www.CDC.gov/diabetes accessed September 6, 2005.
24. Sjostrom L, Lindroos AK, Peltonen M, et al. Swedish Obese Subjects Study Scientific Group. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004; 351: 2683-93.
25. Dixon JB, O'Brien PE. Changes in comorbidities and improvements in quality of life after LAP-BAND placement. Am J Surg 2002; 184: 51S-54S.
26. Iossa S, Mollica MP, Lionetti L, Crescenzo R, Tasso R, Liverini G. A possible link between skeletal muscle mitochondrial efficiency and age-induced insulin resistance. Diabetes 2004; 53: 2861-6.
27. Schauer PR, Burguera B, Ikramuddin S, et al. Effect of laparoscopic roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003; 238: 467-484.
28. Sugerman H, Wolfe L, Sica D, et al. Diabetes and hypertension in severe obesity and effects of gastric bypass induced weight loss. Ann Surg 2003; 237: 751-8.
29. Goodpaster BH, Krishnaswami S, Harris TB, et al. Obesity, regional body fat distribution, and the metabolic syndrome in older men and women. Arch Intern Med 2005; 165: 777-83.
30. Miller WM, Nori Janosz KE, Yanez J, McCullough PA. Effects of weight loss and pharmacotherapy on inflammatory markers of cardiovascular disease. Expert Rev Cardiovasc Ther 2005; 3: 743-59.
31. Chambers JC, Eda S, Bassett P, et al. C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites. Circulation 2001; 104: 145-150.
32. Pories W, Albrecht R. Etiology of type II diabetes mellitus: role of the forgut. World J Surg 2001; 25: 527-31.
33. Kellum JM, Kuemmerle JF, O'Dorisio TM, et al. Gastrointesinal hormone response to meals before and after gastric bypass and vertical banded gastroplasty. Ann Surg 1990; 211: 763-771.
34. Greenway S, Greenway F, Klein S. Effects of obesity surgery on non-insulin dependent diabetes mellitus. Arch Surg 2002; 137: 1109-17.
35. Adami GF, Cordera R, Camerini G, Marinari GM, Scopinaro N. Recovery of insulin sensitivity in obese patients at short term after biliopancreatic diversion. J Surg Res 2003; 113: 217-221.
36. Wickremesekera K, Miller G, Naotunne TD, et al. Loss of insulin resistance after roux-en-Y gastric bypass surgery: a time course study. Obes Surg 2005; 15: 474-81.
37. Camastra S, Manco M, Mari A, et al. Beta-cell function in morbidly obese subjects during free living: long-term effects of weight loss. Diabetes 2005; 54: 2382-9.
38. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292: 1724-37.
39. Orchard TJ, Temprosa M, Goldberg R, et al. Diabetes Prevention Program Research Group. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial. Ann Intern Med 2005; 142: 611-9.
40. Wing RR, Marcus MD, Salata R, Epstein LH, Miaskiewicz S, Blair EH. Effects of a very-low-calorie diet in long-term glycemic control in obese type 2 diabetic subjects. Arch Intern Med 1991; 151: 1331-40.
41. Astrup A, Grunwald GK, Melanson EL, Saris WH, Hill JO. The role of low-fat diets in body weight control: a meta-analysis of ad libitum dietary intervention studies. Int J Obes Relat Metab Disord 2000; 24: 1545-52.
42. Anderson JW, Konz EC, Frederich RC, Wood CL. Long-term weight-loss maintenance: a meta-analysis of US studies. Am J Clin Nutr 2001; 74: 579-84.
43. Haddock CK, Poston WS, Dill PL, Foreyt JP, Ericsson M. Pharmacotherapy for obesity: a quantitative analysis of four decades of published randomized clinical trials. Int J Obes Relat Metab Disord 2002; 26: 262-73.
44. Monteforte MJ, Turkelson CM. Bariatric surgery for morbid obesity. Obes Surg 2000; 10: 391-401.
45. Hannum S, Carson L, Evans E, et al. Use of portion-controlled entrees enhances weight loss in women. Obes Res 2004; 12: 538-546.
46. Sartorio A, Lafortuna CL, Vangeli V, Tavani A, Bosetti C, La Vecchia C. Short-term changes of cardiovascular risk factors after a non-pharmacological body weight reduction program. Eur J Clin Nutr 2001; 55: 865-9.
47. Heilbronn L, de Jong L, Frisard M, et al. Effect of 6-month calorie restriction on biomarkers of longevity, metabolic adaptation, and oxidative stress in overweight individuals. JAMA 2006; 295: 1539-1548.